KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 7,900.00
+360.00 (4.77%)
At close: Aug 24, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 82.24 billion as of August 24, 2026. Its market cap has decreased by -46.98% in one year.
Market Cap
82.24B
Enterprise Value
87.79B
Revenue
93.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,900.00
ChartMarket Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 82.24B, a decrease of -55.25%. That is a compound annual growth rate of -12.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 82.24B | -42.00% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DongKoo Bio & Pharma | 99.79B |
| OPTUS Pharmaceutical | 98.82B |
| H.PIO | 85.75B |
| Sam-A Pharm. | 83.55B |
| Daehan Nupharm | 78.32B |
| Polaris AI Pharma | 68.41B |
| Optipharm.CO.,LTD | 66.97B |
| Hwail Pharmaceutical | 66.84B |